<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endoscopic ultrasound (EUS) is considered the most accurate tool for the TNM staging of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, but its role in early Barrett's <z:hpo ids='HP_0002664'>neoplasia</z:hpo> is still debatable </plain></SENT>
<SENT sid="1" pm="."><plain>The aim was to evaluate the utility of EUS in Barrett's patients prior to therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Retrospective review of 109 patients enrolled in a treatment protocol for Barrett's <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in our institution </plain></SENT>
<SENT sid="3" pm="."><plain>EUS assessment was classified as suspicious for invasion in 19 patients; 84% of them had no evidence of invasion in final pathology </plain></SENT>
<SENT sid="4" pm="."><plain>The assessment of depth of invasion of Barrett's <z:hpo ids='HP_0002664'>neoplasia</z:hpo> based solely on EUS findings leads to overstaging in most patients </plain></SENT>
</text></document>